A Harvard Medical School Telestroke Capacity Study published in JAMA Neurology (JAMA Neurol. Published online March 1, 2021. doi:10.1001/jamaneurol.2021.0023) is the first of its kind conducted to explore telestroke capacity. The results demonstrated the benefit of telestroke by improving utilization of reperfusion therapies as well as promoting lower short-term mortality compared to in-person stroke treatment.
Visit https://jamanetwork.com/journals/jamaneurology/article-abstract/2776793 to read the article.